{"id":6477,"date":"2023-08-14T17:59:15","date_gmt":"2023-08-14T17:59:15","guid":{"rendered":"https:\/\/quebecvalves.ulaval.ca\/?page_id=6477"},"modified":"2026-01-02T17:31:39","modified_gmt":"2026-01-02T22:31:39","slug":"the-corelab","status":"publish","type":"page","link":"https:\/\/quebecvalves.ulaval.ca\/?page_id=6477&lang=en","title":{"rendered":"The CoreLab"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"6477\" class=\"elementor elementor-6477\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-10829e5 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"10829e5\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-custom\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-41f2f8b\" data-id=\"41f2f8b\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-1899fdc elementor-widget elementor-widget-heading\" data-id=\"1899fdc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\"><span style=\"font-size: 35px;text-align: center\">The Centralized Echocardiography Analysis Laboratory<\/span><span style=\"font-size: 35px;text-align: center\"> (CoreLab)<\/span><\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-547e43f elementor-widget elementor-widget-text-editor\" data-id=\"547e43f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>The Echocardiographic Core Laboratory (ECL), founded in 2010, provides centralized third-party interpretation of echocardiographic studies for clinical trials worldwide. It collaborates as a research partner with clinical trial investigators and industry sponsors.<\/p><p>Specifically, the ECL offers echocardiographic measurements for clinical investigations and trials that use echocardiography for patient eligibility, study criteria, and endpoints.<\/p><p>Dr. Pibarot serves as the director of the Echocardiography Core Lab, leading a team of approximately twenty members including coordinators, internal auditors, echocardiography technicians, and certified cardiologists who are experts in echocardiographic analysis.<\/p><p>To date, they have analyzed over 30,000 echocardiograms from multiple studies worldwide, making the Echocardiographic Core Lab one of the most sought-after and recognized labs in the field of valvular and structural heart diseases.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-6367f6f\" data-id=\"6367f6f\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-c09cf0e elementor-absolute elementor-widget elementor-widget-image\" data-id=\"c09cf0e\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;_position&quot;:&quot;absolute&quot;}\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"2143\" height=\"1398\" src=\"https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2024\/04\/iStock-1188396421.jpg\" class=\"attachment-full size-full wp-image-5969\" alt=\"\" srcset=\"https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2024\/04\/iStock-1188396421.jpg 2143w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2024\/04\/iStock-1188396421-300x196.jpg 300w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2024\/04\/iStock-1188396421-1024x668.jpg 1024w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2024\/04\/iStock-1188396421-768x501.jpg 768w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2024\/04\/iStock-1188396421-1536x1002.jpg 1536w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2024\/04\/iStock-1188396421-2048x1336.jpg 2048w\" sizes=\"(max-width: 2143px) 100vw, 2143px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5d15814 elementor-absolute elementor-widget elementor-widget-image\" data-id=\"5d15814\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;_position&quot;:&quot;absolute&quot;}\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2024\/04\/iStock-1190647441-1024x683.jpg\" class=\"attachment-large size-large wp-image-5970\" alt=\"\" srcset=\"https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2024\/04\/iStock-1190647441-1024x683.jpg 1024w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2024\/04\/iStock-1190647441-300x200.jpg 300w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2024\/04\/iStock-1190647441-768x512.jpg 768w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2024\/04\/iStock-1190647441-1536x1024.jpg 1536w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2024\/04\/iStock-1190647441-2048x1365.jpg 2048w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-e859152 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"e859152\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-9f756d5\" data-id=\"9f756d5\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-78d7f2d elementor-absolute elementor-widget elementor-widget-heading\" data-id=\"78d7f2d\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;_position&quot;:&quot;absolute&quot;}\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">CoreLab Managers<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-6102836 elementor-section-content-middle elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"6102836\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-124b3e6\" data-id=\"124b3e6\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6e074cf elementor-widget__width-initial elementor-absolute elementor-position-top elementor-widget elementor-widget-image-box\" data-id=\"6e074cf\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;_position&quot;:&quot;absolute&quot;}\" data-widget_type=\"image-box.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-image-box-wrapper\"><figure class=\"elementor-image-box-img\"><img decoding=\"async\" width=\"1707\" height=\"2560\" src=\"https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/07\/Isabelle-Fortin-scaled.jpeg\" class=\"attachment-full size-full wp-image-3430\" alt=\"\" srcset=\"https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/07\/Isabelle-Fortin-scaled.jpeg 1707w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/07\/Isabelle-Fortin-200x300.jpeg 200w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/07\/Isabelle-Fortin-683x1024.jpeg 683w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/07\/Isabelle-Fortin-768x1152.jpeg 768w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/07\/Isabelle-Fortin-1024x1536.jpeg 1024w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/07\/Isabelle-Fortin-1365x2048.jpeg 1365w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/07\/Isabelle-Fortin-8x12.jpeg 8w\" sizes=\"(max-width: 1707px) 100vw, 1707px\" \/><\/figure><div class=\"elementor-image-box-content\"><h4 class=\"elementor-image-box-title\">Isabelle Fortin<\/h4><p class=\"elementor-image-box-description\">Chief Coordinator<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-421a405 elementor-widget__width-initial elementor-absolute elementor-position-top elementor-widget elementor-widget-image-box\" data-id=\"421a405\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;_position&quot;:&quot;absolute&quot;}\" data-widget_type=\"image-box.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-image-box-wrapper\"><figure class=\"elementor-image-box-img\"><img loading=\"lazy\" decoding=\"async\" width=\"1707\" height=\"2560\" src=\"https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/07\/Philippe-Pibarot-scaled.jpg\" class=\"attachment-full size-full wp-image-3434\" alt=\"\" srcset=\"https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/07\/Philippe-Pibarot-scaled.jpg 1707w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/07\/Philippe-Pibarot-200x300.jpg 200w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/07\/Philippe-Pibarot-683x1024.jpg 683w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/07\/Philippe-Pibarot-768x1152.jpg 768w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/07\/Philippe-Pibarot-1024x1536.jpg 1024w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/07\/Philippe-Pibarot-1365x2048.jpg 1365w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/07\/Philippe-Pibarot-8x12.jpg 8w\" sizes=\"(max-width: 1707px) 100vw, 1707px\" \/><\/figure><div class=\"elementor-image-box-content\"><h4 class=\"elementor-image-box-title\">Philippe Pibarot<\/h4><p class=\"elementor-image-box-description\">Laboratory Director<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-hsdq1g2 elementor-section-content-middle elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"hsdq1g2\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t\t<div class=\"elementor-background-overlay\"><\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-no\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-546b9f5\" data-id=\"546b9f5\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-216bdf1 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"216bdf1\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-wide\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-34d33e2\" data-id=\"34d33e2\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-b1fc1c6 elementor-widget__width-initial elementor-absolute elementor-position-top elementor-widget elementor-widget-image-box\" data-id=\"b1fc1c6\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;_position&quot;:&quot;absolute&quot;}\" data-widget_type=\"image-box.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-image-box-wrapper\"><figure class=\"elementor-image-box-img\"><img loading=\"lazy\" decoding=\"async\" width=\"1707\" height=\"2560\" src=\"https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/07\/N-Cote_DSC_9865-scaled.jpg\" class=\"attachment-full size-full wp-image-3433\" alt=\"\" srcset=\"https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/07\/N-Cote_DSC_9865-scaled.jpg 1707w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/07\/N-Cote_DSC_9865-200x300.jpg 200w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/07\/N-Cote_DSC_9865-683x1024.jpg 683w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/07\/N-Cote_DSC_9865-768x1152.jpg 768w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/07\/N-Cote_DSC_9865-1024x1536.jpg 1024w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/07\/N-Cote_DSC_9865-1365x2048.jpg 1365w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/07\/N-Cote_DSC_9865-8x12.jpg 8w\" sizes=\"(max-width: 1707px) 100vw, 1707px\" \/><\/figure><div class=\"elementor-image-box-content\"><h4 class=\"elementor-image-box-title\">Nancy C\u00f4t\u00e9<\/h4><p class=\"elementor-image-box-description\">Internal Auditor<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-3f072ac\" data-id=\"3f072ac\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-fa7c555 elementor-widget__width-initial elementor-absolute elementor-position-top elementor-widget elementor-widget-image-box\" data-id=\"fa7c555\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;_position&quot;:&quot;absolute&quot;}\" data-widget_type=\"image-box.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-image-box-wrapper\"><figure class=\"elementor-image-box-img\"><img loading=\"lazy\" decoding=\"async\" width=\"1707\" height=\"2560\" src=\"https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/08\/A-Lacombe-2-scaled.jpg\" class=\"attachment-full size-full wp-image-4371\" alt=\"\" srcset=\"https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/08\/A-Lacombe-2-scaled.jpg 1707w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/08\/A-Lacombe-2-200x300.jpg 200w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/08\/A-Lacombe-2-683x1024.jpg 683w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/08\/A-Lacombe-2-768x1152.jpg 768w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/08\/A-Lacombe-2-1024x1536.jpg 1024w, https:\/\/quebecvalves.ulaval.ca\/wp-content\/uploads\/2023\/08\/A-Lacombe-2-1365x2048.jpg 1365w\" sizes=\"(max-width: 1707px) 100vw, 1707px\" \/><\/figure><div class=\"elementor-image-box-content\"><h4 class=\"elementor-image-box-title\">Annie Lacombe<\/h4><p class=\"elementor-image-box-description\">Coordinator<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-1704575 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"1704575\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-70c61ed\" data-id=\"70c61ed\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-5f2672a elementor-widget elementor-widget-heading\" data-id=\"5f2672a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Other CoreLab Members :<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e950e7d elementor-widget elementor-widget-text-editor\" data-id=\"e950e7d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li><b>Internal Auditor Assistants :<\/b>\u00a0Camille Ollivier.<\/li><\/ul><ul><li><b style=\"font-style: inherit; text-indent: -18pt;\">Assistants Coordinators :<\/b><span style=\"font-size: 16px; text-indent: -18pt;\"> Yvette Parent et Martine Parent.<\/span><\/li><\/ul><ul><li style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo1;\"><span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';\">\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 <\/span><b>Cardiologists :<\/b>\u00a0Mathieu Bernier, Jonathan Beaudoin, Ezequiel Guzzetti, Iria Silva Conde, Pierre-Yves Turgeon, Am\u00e9lie Paquin, Abdellaziz Dahou, Antonela Zanuttini, Haifa Mahjoub, Carlos Guiliani, Alexis Theron, Benjamin Camacho, Alberto Alperi, Paolo Springhetti, Tim Woods, Gisela Teixido Tura.<\/li><\/ul><ul><li style=\"text-indent: -18.0pt; mso-list: l0 level1 lfo1;\"><span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';\">\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 <\/span><b>Technologists in Echocardiography :<\/b>\u00a0Catherine Pichette, Mathieu Roux, Danielle Tardif, \u00c9lyse Morissette, Genevi\u00e8ve Cabana, Jenny Carrier, Linda Rouleau, Audrey Labelle.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-10a2c3c elementor-widget elementor-widget-heading\" data-id=\"10a2c3c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Our Ongoing ELC Projects<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-236c6fd elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"236c6fd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><b>\u2013\u00a0<\/b><span style=\"font-style: inherit; color: var(--ast-global-color-3);\"><span lang=\"EN-CA\"><b><u>ACURATE IDE<\/u> :<\/b><\/span><\/span> <b><span lang=\"EN-CA\" style=\"font-style: inherit; color: var(--ast-global-color-3);\">Safety and Effectiv<\/span><span lang=\"EN-CA\" style=\"font-style: inherit; color: var(--ast-global-color-3);\">eness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement<\/span><\/b><span lang=\"EN-CA\" style=\"font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\">. To evaluate safety and effectiveness of the ACURATE Transfemoral Aortic Valve System for transcatheter aortic valve replacement (TAVR) in subjects with severe native aortic stenosis who are indicated for TAVR. <b><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT03735667\">https:\/\/clinicaltrials.gov\/study\/NCT03735667<\/a><\/b><\/span><\/p><p><b>\u2013\u00a0<u>PARTNER 2 &#8211; SAPIEN 3<\/u> :\u00a0<\/b><span style=\"font-size: 16px; font-style: inherit; color: var(--ast-global-color-3);\"><span lang=\"EN-CA\"><b>PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II &#8211; XT Intermediate and High Risk (PII A)<\/b><\/span><\/span><span lang=\"EN-CA\" style=\"font-size: 16px; font-style: inherit; color: var(--ast-global-color-3);\"><b>.<\/b><span style=\"font-weight: inherit;\"> The purpose of this trial is to determine the safety and effectiveness of the Edwards SAPIEN XT transcatheter heart valve and delivery systems which are intended for use in patients with symptomatic, calcific, severe aortic stenosis<\/span><\/span><span style=\"font-weight: inherit; letter-spacing: 0.2px; color: var(--ast-global-color-3);\">.\u00a0<\/span><a style=\"font-weight: inherit; letter-spacing: 0.2px; background-color: #ebf4f8;\" href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01314313\" target=\"_blank\" rel=\"noopener\"><b>https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01314313<\/b><\/a><\/p><p style=\"font-size: 15px; font-style: normal; letter-spacing: 0.2px; text-align: justify;\"><b style=\"font-style: inherit; letter-spacing: 0.2px; color: var(--ast-global-color-3);\">\u2013\u00a0<u>PARTNER 3<\/u> :\u00a0<\/b><span style=\"font-style: inherit; font-weight: inherit; letter-spacing: 0.2px; color: var(--ast-global-color-3); font-size: 16px;\"><span lang=\"EN-CA\"><b>PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis (P3).<\/b> <\/span><\/span><span lang=\"EN-CA\" style=\"font-style: inherit; font-weight: inherit; letter-spacing: 0.2px; color: var(--ast-global-color-3); font-size: 16px;\">To establish the safety and effectiveness ofthe Edwards SAPIEN 3 Transcatheter Heart Valve (THV) in patients with severe, calcific aortic stenosis who are at low operative risk for standard aortic valve replacement<\/span><span style=\"font-weight: inherit; letter-spacing: 0.2px; color: var(--ast-global-color-3);\">.<\/span><span style=\"font-weight: inherit; letter-spacing: 0.2px; color: var(--ast-global-color-3);\"><b>\u00a0<a style=\"letter-spacing: 0.2px; background-color: #ebf4f8;\" href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02675114\" target=\"_blank\" rel=\"noopener\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02675114<\/a><\/b><\/span><\/p><p style=\"font-size: 15px; font-style: normal; letter-spacing: 0.2px; text-align: justify;\"><b style=\"letter-spacing: 0.2px; color: var(--ast-global-color-3);\">\u2013\u00a0<\/b><span style=\"font-style: inherit; font-weight: inherit; letter-spacing: 0.2px; color: var(--ast-global-color-3); font-size: 16px;\"><span lang=\"EN-CA\"><b style=\"text-decoration-line: underline;\">EARLY TAVR<\/b><b> :<\/b> <b>Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis (EARLY TAVR).<\/b><\/span><\/span><span lang=\"EN-CA\" style=\"font-style: inherit; font-weight: inherit; letter-spacing: 0.2px; color: var(--ast-global-color-3); font-size: 16px;\"> This study will evaluate the safety and effectiveness of the Edwards SAPIEN 3\/SAPIEN 3 Ultra Transcatheter Heart Valve (THV) compared with clinical surveillance (CS) in asymptomatic patients with severe, calcific aortic stenosis.\u00a0<\/span><a style=\"font-weight: inherit; letter-spacing: 0.2px; background-color: #ebf4f8;\" href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03042104\" target=\"_blank\" rel=\"noopener\"><b>https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03042104<\/b><\/a><\/p><p style=\"font-size: 15px; font-style: normal; letter-spacing: 0.2px; text-align: justify;\"><b style=\"letter-spacing: 0.2px; color: var(--ast-global-color-3);\">\u2013\u00a0<\/b><span style=\"font-style: inherit; font-weight: inherit; letter-spacing: 0.2px; color: var(--ast-global-color-3); font-size: 16px;\"><span lang=\"EN-CA\"><b style=\"text-decoration-line: underline;\">TAVR UNLOAD<\/b><b> :<\/b> <b>Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With Advanced Heart Failure. <\/b><\/span><\/span><span lang=\"EN-CA\" style=\"font-style: inherit; font-weight: inherit; letter-spacing: 0.2px; color: var(--ast-global-color-3); font-size: 16px;\">The objective of this study is to determine the safety and efficacy of transcatheter aortic valve replacement (TAVR) via a transfemoral approach in HF patients with moderate AS as compared with OHFT<\/span><span style=\"font-weight: inherit; letter-spacing: 0.2px; color: var(--ast-global-color-3);\">.<\/span><span style=\"font-weight: inherit; letter-spacing: 0.2px; color: var(--ast-global-color-3);\">\u00a0<a style=\"background-color: #ebf4f8; letter-spacing: 0.2px;\" href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02661451\" target=\"_blank\" rel=\"noopener\"><b>https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02661451<\/b><\/a><\/span><\/p><p style=\"font-size: 15px; font-style: normal; letter-spacing: 0.2px; text-align: justify;\"><b style=\"letter-spacing: 0.2px; color: var(--ast-global-color-3);\">\u2013\u00a0<u>V-WAVE<\/u> :<\/b><span style=\"letter-spacing: 0.2px; color: var(--ast-global-color-3);\">\u00a0<\/span><span style=\"font-style: inherit; font-weight: inherit; letter-spacing: 0.2px; color: var(--ast-global-color-3); font-size: 16px;\"><span lang=\"EN-CA\"><b>The V-Wave Shunt: FIM Safety and Feasibility Study (VW-SP-1).<\/b> <\/span><\/span><span lang=\"EN-CA\" style=\"font-style: inherit; font-weight: inherit; letter-spacing: 0.2px; color: var(--ast-global-color-3); font-size: 16px;\"><span style=\"font-weight: inherit;\">The V-Wave a trial-septal shunt implant is intended for the reduction of elevated left atrial filling pressures (&lsquo;Left Atrial Decompression&rsquo;) in chronic, New York Heart Association (NYHA) class III -IV, Heart Failure (HF) patients. <\/span><b><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT01965015\">https:\/\/clinicaltrials.gov\/study\/NCT01965015<\/a><\/b><\/span><\/p><p style=\"font-size: 15px; font-style: normal; letter-spacing: 0.2px; text-align: justify;\"><b style=\"font-size: 16px; font-style: inherit; color: var(--ast-global-color-3);\"><span style=\"font-size: 15px; letter-spacing: 0.2px;\">\u2013\u00a0<\/span><\/b><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><span lang=\"EN-CA\"><b><u>BACE<\/u> :<\/b> <b>Evaluation of Safety and Efficacy of the BACE\u2122 Device in the Treatment of Functional Mitral Valve Regurgitation [FMR (BACE).<\/b><\/span><\/span><span lang=\"EN-CA\" style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"> The preclinical and clinical evidence of safety and efficacy with the BACE device (concept and feasibility) paved the way for the evaluation of the BACE device\u00a0<\/span><span style=\"font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3); letter-spacing: 0.2px;\">(Cardiac Phoenix)<\/span><span style=\"font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3); letter-spacing: 0.2px;\">\u00a0<\/span><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\">in this prospective, multi-center, single-arm, self-controlled study for safety and efficacy in the treatment of ffunctional MR in a maximum of 60 adult subjects.\u00a0 <\/span><span style=\"font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3); letter-spacing: 0.2px;\">\u00a0<\/span><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: #191970;\"><span style=\"font-size: 15px; letter-spacing: 0.2px;\"><b><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT02701972\">https:\/\/clinicaltrials.gov\/study\/NCT02701972<\/a><\/b><\/span><\/span><\/p><p style=\"font-size: 15px; font-style: normal; letter-spacing: 0.2px; text-align: justify;\"><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b>\u2013\u00a0<u>LEAFLEX<\/u>\u00a0<\/b><span style=\"font-weight: inherit;\">:<\/span><\/span><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\">\u00a0<\/span><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b>The Leaflex\u2122 Early Feasibility Study<\/b><\/span><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\">.\u00a0<\/span><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\">A Prospective, Multicenter, Non-randomized, Single-arm, Open-label Clinical Study to Demonstrate the Safety and Performance of the Leaflex\u2122 Performer in the treatment of patients with symptomatic, severe aortic stenosis. Subjects will be seen at pre- and post procedure, discharge, 30 days and at 3, 6, 9- and 12-months post procedure. <\/span><b style=\"font-size: 16px; font-style: inherit; color: var(--ast-global-color-3);\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT04636073\">https:\/\/clinicaltrials.gov\/study\/NCT04636073<\/a><\/b><\/p><p style=\"font-size: 15px; font-style: normal; letter-spacing: 0.2px; text-align: justify;\"><span lang=\"EN-CA\" style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b>&#8211;\u00a0<\/b><b><u>SHORTCUT<\/u> :\u00a0<\/b><\/span><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\">\u00a0A Prospective, Multicenter, Non-Randomized, Single-Arm, Open-Label Clinical Study to Demonstrate the Safety and Effectiveness of the ShortCut\u2122 Device (The ShortCut\u2122 Study)<\/span><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\">.\u00a0<\/span><b style=\"font-size: 16px; font-style: inherit; color: var(--ast-global-color-3);\"><a href=\"https:\/\/www.clinicaltrials.gov\/study\/NCT04952909\">https:\/\/www.clinicaltrials.gov\/study\/NCT04952909<\/a><\/b><\/p><p style=\"font-size: 15px; font-style: normal; letter-spacing: 0.2px; text-align: justify;\"><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b>&#8211;\u00a0<\/b><\/span><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b><u>DISCORDANCE<\/u> :\u00a0<\/b><\/span><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b>Standardized Invasive Hemodynamics for Elevated Gradients Post TAVR (DISCORDANCE TAVR).<\/b><\/span><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"> This study will determine the discordance between echocardiography-derived and invasive transaortic gradients, as determined by a consistent and reproducible technique (Standardized Invasive Hemodynamics) post-TAVR.\u00a0<\/span><b style=\"font-size: 16px; font-style: inherit; color: var(--ast-global-color-3);\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT04827238\">https:\/\/clinicaltrials.gov\/study\/NCT04827238<\/a><\/b><\/p><p style=\"font-size: 15px; font-style: normal; letter-spacing: 0.2px; text-align: justify;\"><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b>&#8211;<\/b><\/span>\u00a0<span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b><u>BEST<\/u> :\u00a0\u00a0<\/b><\/span><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b>Balloon-expandable vs Self-Expanding Transcatheter Heart Valve (BEST)<\/b><\/span><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\">. It is a randomized which is evaluating the impact of transcatheter heart valve (THV) transplantation: Self-expanding\/Auto-extensible (SE) versus Balloon-expandable\/Extensible par ballon (BE) on the risk of all-cause mortality at 90 days and 1 year.\u00a0<\/span><b style=\"font-size: 16px; font-style: inherit; color: var(--ast-global-color-3);\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT05454150\">https:\/\/clinicaltrials.gov\/study\/NCT05454150<\/a><\/b><\/p><p style=\"font-size: 15px; font-style: normal; letter-spacing: 0.2px; text-align: justify;\"><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b>&#8211; <u>ALLIANCE<\/u> :\u00a0\u00a0<\/b><\/span><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b>Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve.<\/b><\/span><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"> The objective of this study is to establish the safety and effectiveness of the Edwards SAPIEN X4 Transcatheter Heart Valve (THV) in subjects with symptomatic, severe, calcific aortic stenosis (AS).<\/span><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\">\u00a0<\/span><b style=\"font-size: 16px; font-style: inherit; color: var(--ast-global-color-3);\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT05172960\">https:\/\/clinicaltrials.gov\/study\/NCT05172960<\/a><\/b><\/p><p style=\"font-size: 15px; font-style: normal; letter-spacing: 0.2px; text-align: justify;\"><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b>&#8211; <\/b><\/span><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b><u>PROGRESS<\/u> :\u00a0<\/b><\/span><b style=\"font-size: 16px; font-style: inherit; color: var(--ast-global-color-3);\"><span style=\"font-style: inherit; color: var(--ast-global-color-3);\">Management of Moderate Aortic Stenosis by Clinical Surveillance or\u00a0<\/span><span style=\"font-style: inherit; color: var(--ast-global-color-3);\">Transcatheter Aortic Valve Replacement\u00a0<\/span><span style=\"color: var(--ast-global-color-3); font-style: inherit;\">(PROGRESS).<\/span><\/b><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"> This study objective is to establish the safety and effectiveness\u00a0<\/span><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\">of the Edwards SAPIEN 3 \/ SAPIEN 3 Ultra \/ SAPIEN 3 Ultra RESILIA Transcatheter\u00a0<\/span><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\">Heart Valve systems in subjects with moderate, calcific aortic stenosis. <\/span><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT04889872\">https:\/\/clinicaltrials.gov\/study\/NCT04889872<\/a><\/b><\/span><\/p><p style=\"font-size: 15px; font-style: normal; letter-spacing: 0.2px; text-align: justify;\"><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b>&#8211;<\/b><\/span> <span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b><u>RHEIA<\/u> :\u00a0<\/b><\/span><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b>RHEIA (Randomized research in women All Comers With Aortic Stenosis)<\/b><span style=\"font-weight: inherit;\">. Purpose of this prospective, randomized, controlled, multi-center study is to evaluate the safety and efficacy of Transcatheter Aortic Valve Implantation (TAVI) as compared to surgical aortic valve replacement (SAVR) in female patients with severe symptomatic aortic stenosis. <\/span><\/span><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b><a href=\"http:\/\/RHEIA : RHEIA (Randomized research in women All Comers With Aortic Stenosis). Purpose of this prospective, randomized, controlled, multi-center study is to evaluate the safety and efficacy of Transcatheter Aortic Valve Implantation (TAVI) as compared to surgical aortic valve replacement (SAVR) in female patients with severe symptomatic aortic stenosis. https:\/\/clinicaltrials.gov\/study\/NCT04160130\">https:\/\/clinicaltrials.gov\/study\/NCT04160130<\/a><\/b><\/span><\/p><p style=\"font-size: 15px; font-style: normal; letter-spacing: 0.2px; text-align: justify;\"><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b>&#8211;<\/b><\/span> <span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b><u>RESILIENCE<\/u> :\u00a0<\/b><\/span><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b>RESILIENCE Trial: Evaluation of the Durability of Aortic Bioprostheses\/Valves With RESILIA Tissue in Subjects Under 65.<\/b><span style=\"font-weight: inherit;\"> The objective of this observational trial is to determine time to valve failure due to valve deterioration requiring re-intervention and collect\/investigate early potential predictors of valve durability (e.g., calcification and hemodynamic deterioration) in RESILIA tissue valves.<\/span><\/span><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\">\u00a0<\/span><b style=\"font-size: 16px; font-style: inherit; color: var(--ast-global-color-3);\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT03680040\"><span style=\"font-style: inherit; color: var(--ast-global-color-3);\">h<\/span><span style=\"font-style: inherit; color: var(--ast-global-color-3);\">ttps:\/\/clinicaltrials.gov\/study\/NCT03680040<\/span><\/a><\/b><\/p><p style=\"font-size: 15px; font-style: normal; letter-spacing: 0.2px; text-align: justify;\"><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b>&#8211;<\/b><\/span> <span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b><u>VSLING<\/u> :<\/b>\u00a0<\/span><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b>Vsling\u2122 III: Clinical Evaluation of the Vsling\u2122 Device for Ventricular Repair in Patients With Heart Failure (Vsling III). <\/b><span style=\"font-weight: inherit;\">Prospective, multi-center, open-label clinical study of the feasibility and initial safety and performance of the Vsling\u2122 in patients with heart failure (HF) with evidence of reduced left ventricular ejection fraction, associated with ventricular dilation.<\/span><\/span><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\">\u00a0<\/span><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT06002386\">https:\/\/clinicaltrials.gov\/study\/NCT06002386<\/a><\/b><\/span><\/p><p style=\"font-size: 15px; font-style: normal; letter-spacing: 0.2px; text-align: justify;\"><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b>&#8211;<\/b><\/span> <span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b><u>VIVA<\/u> :\u00a0<\/b><\/span><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b>CoreValve VIVA Study Evaluation of the Clinical Outcomes of CoreValve in Degenerative Surgical Aortic Bioprosthesis.<\/b><span style=\"font-weight: inherit;\"> This observational study is intended to collect real-world (post-approval use) data regarding the clinical utility and performance of the Medtronic CoreValve\u00ae System for Transcatheter Aortic Valve Implantation (TAVI).\u00a0<\/span><\/span><b style=\"font-size: 16px; font-style: inherit; color: var(--ast-global-color-3);\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT02209298\">https:\/\/clinicaltrials.gov\/study\/NCT02209298<\/a><\/b><\/p><p style=\"font-size: 15px; font-style: normal; letter-spacing: 0.2px; text-align: justify;\"><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b>&#8211;<\/b><\/span> <span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b><u>LYTEN<\/u> :\u00a0<\/b><\/span><span style=\"font-size: 16px; font-style: inherit; font-weight: inherit; color: var(--ast-global-color-3);\"><b>Comparison of the Balloon-Expandable Edwards Valve and Self-Expandable CoreValve Evolut R or Evolut PRO System for the Treatment of Small, Severely Dysfunctional Surgical Aortic Bioprotheses. The &lsquo;LYTEN&rsquo; Trial. <\/b><span style=\"font-weight: inherit;\">The treatment with transcatheter aortic valve implantation (TAVI) of patients with small (\u226423mm) surgical bioprostheses remains a challenge due to the increased transvalvular residual gradients and high rates of severe prosthesis-patient mismatch (PPM) following the procedure.\u00a0<\/span><\/span><a style=\"font-size: 16px; font-style: inherit; font-weight: inherit; background-color: #ebf4f8;\" href=\"https:\/\/clinicaltrials.gov\/study\/NCT03520101\"><b>https:\/\/clinicaltrials.gov\/study\/NCT035201<\/b><b>01<\/b><\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-e57471c elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"e57471c\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-0370133\" data-id=\"0370133\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-3b705f3 elementor-section-full_width elementor-section-content-top elementor-section-height-default elementor-section-height-default\" data-id=\"3b705f3\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-no\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-6b1eb07\" data-id=\"6b1eb07\" data-element_type=\"column\" data-e-type=\"column\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t<div class=\"elementor-background-overlay\"><\/div>\n\t\t\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-54702a0 elementor-section-full_width elementor-section-height-default elementor-section-height-default\" data-id=\"54702a0\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-inner-column elementor-element elementor-element-4df3e4e\" data-id=\"4df3e4e\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-92e93d1 elementor-widget__width-initial e-transform e-transform elementor-widget elementor-widget-icon-box\" data-id=\"92e93d1\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;_transform_translateX_effect&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:-15,&quot;sizes&quot;:[]},&quot;_transform_translateY_effect&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:-65,&quot;sizes&quot;:[]},&quot;_transform_scale_effect&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:1.1,&quot;sizes&quot;:[]},&quot;_transform_translateX_effect_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;_transform_translateX_effect_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;_transform_translateY_effect_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;_transform_translateY_effect_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;_transform_scale_effect_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;_transform_scale_effect_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]}}\" data-widget_type=\"icon-box.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-icon-box-wrapper\">\n\n\t\t\t\n\t\t\t\t\t\t<div class=\"elementor-icon-box-content\">\n\n\t\t\t\t\t\t\t\t\t<h3 class=\"elementor-icon-box-title\">\n\t\t\t\t\t\t<span  >\n\t\t\t\t\t\t\tJoin Our CoreLab !\t\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/h3>\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t<p class=\"elementor-icon-box-description\">\n\t\t\t\t\t\tWould you like to get involved in our Echocardiography Analysis Laboratory? It\u2019s very simple! If you are an echocardiography technologist or a cardiologist, just send your CV to the following email address: nancy.cote@criucpq.ulaval.ca\t\t\t\t\t<\/p>\n\t\t\t\t\n\t\t\t<\/div>\n\t\t\t\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>The Centralized Echocardiography Analysis Laboratory (CoreLab) The Echocardiographic Core Laboratory (ECL), founded in 2010, provides centralized third-party interpretation of echocardiographic studies for clinical trials worldwide. It collaborates as a research partner with clinical trial investigators and industry sponsors. Specifically, the ECL offers echocardiographic measurements for clinical investigations and trials that use echocardiography for patient eligibility, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"full-width-container","site-content-style":"unboxed","site-sidebar-style":"unboxed","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-6477","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/quebecvalves.ulaval.ca\/index.php?rest_route=\/wp\/v2\/pages\/6477","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/quebecvalves.ulaval.ca\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/quebecvalves.ulaval.ca\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/quebecvalves.ulaval.ca\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/quebecvalves.ulaval.ca\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6477"}],"version-history":[{"count":14,"href":"https:\/\/quebecvalves.ulaval.ca\/index.php?rest_route=\/wp\/v2\/pages\/6477\/revisions"}],"predecessor-version":[{"id":7395,"href":"https:\/\/quebecvalves.ulaval.ca\/index.php?rest_route=\/wp\/v2\/pages\/6477\/revisions\/7395"}],"wp:attachment":[{"href":"https:\/\/quebecvalves.ulaval.ca\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6477"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}